Another strength of the study was the utilization of a multivariate model to adjust the association of anti-CCP2 antibodies with ILD by other confounders; only two studies have previously used this statistical approach [10, 13], obtaining similar results to those observed in our study. Here, AGBL2 is linked to interstitial lung disease.